Analysed ALKERMES PLC (ALKS:NASDAQ) News Sources
Alkermes Announces Initiation of Phase 3 Brilliance Studies Evaluating Alixorexton for the Treatment of Narcolepsy Type 1 and Type 2
01-04-2026
yahoo.com
Alkermes (ALKS) Nears 52-Week High on Increasing Orexin Receptor Market Interest
01-04-2026
yahoo.com
Alkermes CEO Pops Calls 2026 a “Really Exciting Year” as Orexin Agonists Near Narcolepsy Launch
17-03-2026
marketbeat.com
What is the current price of ALKERMES PLC (ALKS:NASDAQ)?
The current price of ALKERMES PLC (ALKS:NASDAQ) is $33.36.
ALKERMES PLC (ALKS:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALKERMES PLC (ALKS:NASDAQ) since the previous trading day is $-1.56.
ALKERMES PLC (ALKS:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALKERMES PLC (ALKS:NASDAQ) since the previous trading day is -4.4674%.
What is the most recent average sentiment score for ALKERMES PLC (ALKS:NASDAQ)?
The most recent average sentiment score for ALKERMES PLC (ALKS:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for ALKERMES PLC (ALKS:NASDAQ)?
The most recent sentiment for ALKERMES PLC (ALKS:NASDAQ) is .
SEC-8K** Filing Available For ALKERMES PLC (ALKS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.